-
Signature
-
/s/ Brian G. Lloyd, Attorney-in-Fact
-
Issuer symbol
-
MMSI
-
Transactions as of
-
06 Jan 2026
-
Net transactions value
-
-$178,000
-
Form type
-
4
-
Filing time
-
08 Jan 2026, 12:57:30 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Peterson Neil W. |
CHIEF OPERATING OFFICER |
1600 W MERIT PARKWAY, SOUTH JORDAN |
/s/ Brian G. Lloyd, Attorney-in-Fact |
08 Jan 2026 |
0001926221 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
MMSI |
Common Stock, No Par Value |
Options Exercise |
$272,000 |
+5,000 |
+18% |
$54.40 |
33,369 |
06 Jan 2026 |
Direct |
F1 |
| transaction |
MMSI |
Common Stock, No Par Value |
Sale |
$450,000 |
-5,000 |
-15% |
$90.00 |
28,369 |
06 Jan 2026 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
MMSI |
Non-qualified stock options (right to buy) |
Options Exercise |
$0 |
-5,000 |
-100% |
$0.000000 |
0 |
06 Jan 2026 |
Common Stock |
5,000 |
$54.40 |
Direct |
F1, F2 |
| holding |
MMSI |
Non-qualified stock options (right to buy) |
|
|
|
|
|
25,000 |
06 Jan 2026 |
Common Stock |
25,000 |
$68.33 |
Direct |
F3 |
| holding |
MMSI |
Non-qualified stock options (right to buy) |
|
|
|
|
|
13,576 |
06 Jan 2026 |
Common Stock |
13,576 |
$70.58 |
Direct |
F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: